Literature DB >> 15310240

Sulfur-containing arsenical mistaken for dimethylarsinous acid [DMA(III)] and identified as a natural metabolite in urine: major implications for studies on arsenic metabolism and toxicity.

Helle R Hansen1, Andrea Raab, Marcel Jaspars, Bruce F Milne, Jörg Feldmann.   

Abstract

It is vital that methylated trivalent arsenicals [MA(III) and DMA(III)] are described and characterized unequivocally due to their high toxicity. Two different ways of generating the methylated trivalent arsenicals have been practiced-reduction of the methylated pentavalent arsenical either by the sodium-metabisulfite (Na(2)S(2)O(5))/sodium thiosulfate (Na(2)S(2)O(3)) reagent (method A) or by KI, H(2)SO(4), and SO(2) (method B). The shared identity between the products of the two synthetic methods has never been questioned or proven. Here, we characterize and identify the arsenic species formed when reducing DMA(V) by method A or B. Dimethylarsinous acid [DMA(III)] was formed when reducing DMA(V) by method B, but DMA(III) was not the main product of the reaction by method A. The product was revealed by HPLC-ICP-MS coupled simultaneously to HPLC-ES-MS and ES-Q-TOF-MS to have the molecular formula C(2)H(7)OSAs. The structure was further confirmed by (1)H NMR, and ab initio tautomeric energy calculations showed it to be present as Me(2)As(=S)OH (dimethylarsinothioic acid). Dimethylarsinothioic acid was also identified as a metabolite in urine and in wool extract from sheep naturally consuming large amounts of arsenosugars (35 mg of As daily) through their major food source, seaweed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15310240     DOI: 10.1021/tx049978q

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  17 in total

1.  Tissue dosimetry, metabolism and excretion of pentavalent and trivalent monomethylated arsenic in mice after oral administration.

Authors:  Michael F Hughes; Vicenta Devesa; Blakely M Adair; Miroslav Styblo; Elaina M Kenyon; David J Thomas
Journal:  Toxicol Appl Pharmacol       Date:  2005-10-15       Impact factor: 4.219

2.  Preparation of DMMTAV and DMDTAV Using DMAV for Environmental Applications: Synthesis, Purification, and Confirmation.

Authors:  Hosub Lee; Youn-Tae Kim; Seulki Jeong; Hye-On Yoon
Journal:  J Vis Exp       Date:  2018-03-09       Impact factor: 1.355

Review 3.  Human exposure to organic arsenic species from seafood.

Authors:  Vivien Taylor; Britton Goodale; Andrea Raab; Tanja Schwerdtle; Ken Reimer; Sean Conklin; Margaret R Karagas; Kevin A Francesconi
Journal:  Sci Total Environ       Date:  2016-12-24       Impact factor: 7.963

4.  Comparative oxidation state specific analysis of arsenic species by high-performance liquid chromatography-inductively coupled plasma-mass spectrometry and hydride generation-cryotrapping-atomic absorption spectrometry.

Authors:  Jenna Currier; R Jesse Saunders; Lan Ding; Wanda Bodnar; Peter Cable; Tomáš Matoušek; John T Creed; Miroslav Stýblo
Journal:  J Anal At Spectrom       Date:  2013-06-01       Impact factor: 4.023

5.  Folic acid supplementation lowers blood arsenic.

Authors:  Mary V Gamble; Xinhua Liu; Vesna Slavkovich; J Richard Pilsner; Vesna Ilievski; Pam Factor-Litvak; Diane Levy; Shafiul Alam; Mominul Islam; Faruque Parvez; Habibul Ahsan; Joseph H Graziano
Journal:  Am J Clin Nutr       Date:  2007-10       Impact factor: 7.045

6.  Tissue dosimetry, metabolism and excretion of pentavalent and trivalent dimethylated arsenic in mice after oral administration.

Authors:  Michael F Hughes; Vicenta Devesa; Blakely M Adair; Sean D Conklin; John T Creed; Miroslav Styblo; Elaina M Kenyon; David J Thomas
Journal:  Toxicol Appl Pharmacol       Date:  2007-10-22       Impact factor: 4.219

7.  Oxidation State Specific Generation of Arsines from Methylated Arsenicals Based on L- Cysteine Treatment in Buffered Media for Speciation Analysis by Hydride Generation - Automated Cryotrapping - Gas Chromatography-Atomic Absorption Spectrometry with the Multiatomizer.

Authors:  Tomáš Matoušek; Araceli Hernández-Zavala; Milan Svoboda; Lenka Langrová; Blakely M Adair; Zuzana Drobná; David J Thomas; Miroslav Stýblo; Jiří Dědina
Journal:  Spectrochim Acta Part B At Spectrosc       Date:  2008-03       Impact factor: 3.752

Review 8.  The gut microbiome and arsenic-induced disease-iAs metabolism in mice.

Authors:  Yifei Yang; Liang Chi; Yunjia Lai; Yun-Chung Hsiao; Hongyu Ru; Kun Lu
Journal:  Curr Environ Health Rep       Date:  2021-04-14

9.  Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions.

Authors:  J Richard Pilsner; Xinhua Liu; Habibul Ahsan; Vesna Ilievski; Vesna Slavkovich; Diane Levy; Pam Factor-Litvak; Joseph H Graziano; Mary V Gamble
Journal:  Environ Health Perspect       Date:  2008-09-26       Impact factor: 9.031

10.  In vitro intestinal bioavailability of arsenosugar metabolites and presystemic metabolism of thio-dimethylarsinic acid in Caco-2 cells.

Authors:  Larissa Leffers; Christoph A Wehe; Sabine Hüwel; Marc Bartel; Franziska Ebert; Mojtaba S Taleshi; Hans-Joachim Galla; Uwe Karst; Kevin A Francesconi; Tanja Schwerdtle
Journal:  Metallomics       Date:  2013-08       Impact factor: 4.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.